Skip to content

API Data Insights

Numbers don’t lie, companies do

  • All News
  • Market Watch
  • Deep Dives
  • Signals
  • Case Files
  • Opinion
  • Exposés
  • Regulatory

Newswire

FDA Issues Revised Guidance on Drug Delivery Devices
Newswire

FDA Issues Revised Guidance on Drug Delivery Devices

November 3, 2026
The FDA has announced a revised draft guidance for industry titled “Essential Drug Delivery Performance…
Neuralink’s Blindsight Vision Implant Faces Clinical Readiness Questions
Newswire

Neuralink’s Blindsight Vision Implant Faces Clinical Readiness Questions

November 3, 2026
Neuralink’s plans for a brain implant designed to restore vision have gained attention following a…
Fresenius Expands Biosimilars Pipeline with WuXi Biologics Partnership
Newswire

Fresenius Expands Biosimilars Pipeline with WuXi Biologics Partnership

November 3, 2026
Fresenius is expanding its biosimilars strategy through an exclusive development agreement with WuXi Biologics that…
Buccal Drug Delivery Market Expected to Grow Significantly
Newswire

Buccal Drug Delivery Market Expected to Grow Significantly

November 3, 2026
The global market for buccal drug delivery systems is projected to maintain strong growth through…
Inovio’s Voceryq Receives FDA Accelerated Approval
Newswire

Inovio’s Voceryq Receives FDA Accelerated Approval

November 2, 2026
Inovio has secured accelerated approval from the FDA for Voceryq to minimise the frequency of…
MHRA Promotes Yellow Card Reporting for MedSafetyWeek
Newswire

MHRA Promotes Yellow Card Reporting for MedSafetyWeek

November 2, 2026
The MHRA is encouraging patients, parents, carers, and healthcare professionals to report suspected side effects…
Kymera’s eczema trial readout could rival Dupixent
Newswire

Kymera’s eczema trial readout could rival Dupixent

November 2, 2026
Kymera Therapeutics is set to announce data from a mid-stage clinical trial of its lead…
Gene Editing Stocks Surge on FDA Guidance and ESGCT Data
Newswire

Gene Editing Stocks Surge on FDA Guidance and ESGCT Data

November 2, 2026
Shares of gene editing therapy companies surged by double digits recently, driven by two key…
Opentrons Secures $40M for Robotics and AI Expansion
Newswire

Opentrons Secures $40M for Robotics and AI Expansion

November 1, 2026
Opentrons Labworks has raised $40 million from a Series E financing round led by healthcare…
Parse and Nomic Create 100 Million-Cell Dataset
Newswire

Parse and Nomic Create 100 Million-Cell Dataset

November 1, 2026
Parse Biosciences, a QIAGEN company, and Nomic Bio have partnered to generate Cascade, a 100…

About Us

For years we’ve built comprehensive pharmaceutical databases, collecting API, FDF, and excipient suppliers worldwide, with pricing and regulatory details.

Now we present this journal & store: coverage of pharma events, news, and market trends.

Read more →

Contact & Support

Company: API DATA

Location: Israel, Northern District — Gidona

Email: support@api-fdf.com

Connect

Explore our API & FDF Intelligence Database for structured insights on APIs, FDFs, excipients, and compliance worldwide.

Follow updates on LinkedIn.

  • Privacy Policy
  • About Us
  • Home
© API DATA, 2025. All rights reserved Theme: Eternal News By Artify Themes.